Improving prediction of malignancy of cytologically indeterminate thyroid nodules

被引:19
|
作者
Tysome, J. R. [1 ]
Chandra, A. [2 ]
Chang, F. [2 ]
Puwanarajah, P. [1 ]
Elliott, M. [1 ]
Caroll, P. [3 ]
Powrie, J. [3 ]
Hubbard, J. G. [4 ]
Clarke, S. E. M. [5 ]
Jeannon, J. P. [1 ]
Simo, R. [1 ]
机构
[1] Guys Hosp, Dept Otolaryngol Head & Neck Surg, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London, England
[3] Guys & St Thomas NHS Fdn Trust, Dept Endocrinol, London, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Endocrine Surg, London, England
[5] Guys & St Thomas NHS Fdn Trust, Dept Nucl Med, London, England
关键词
FINE-NEEDLE-ASPIRATION; FOLLICULAR NEOPLASIA; PAPILLARY CARCINOMA; INCREASED RISK; LESIONS; OCCULT;
D O I
10.1002/bjs.6734
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Fine-needle aspiration (FNA) is essential in the investigation of thyroid nodules. The British Thyroid Association guidelines recommend clarification of whether follicular nodules are probable follicular neoplasms that require surgical excision. This study assessed the value of the subclassification of cytologically indeterminate thyroid nodules into either follicular neoplasms or other pathology. Methods: The cytology reports of all thyroid FNAs performed between November 2005 and December 2007 at a single institution reported as Thy 3 (follicular lesions) were reviewed. They were reclassified as Thy 3A (probable follicular neoplasm) or Thy 3B (probable non-neoplastic lesion), and subsequently correlated with final clinical outcome to determine the predictive value of this subclassification. Results: Forty-nine specimens were categorized as Thy 3A and 55 as Thy 3B. Of excised lesions, 14 (29 per cent) of 48 Thy 3A and 4 (10 per cent) of 42 Thy 3B nodules were malignant. If Thy 3A were to predict malignancy and Thy 3B benign disease, the sensitivity of the classification was 88 per cent, with a specificity of 55 per cent and negative predictive value of 91 per cent. Conclusion: Subclassification of Thy 3 nodules into Thy 3A and Thy 3B improves the assessment of risk for thyroid malignancy.
引用
收藏
页码:1400 / 1405
页数:6
相关论文
共 50 条
  • [41] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Chin, Patrick D.
    Zhu, Catherine Y.
    Sajed, Dipti P.
    Fishbein, Gregory A.
    Yeh, Michael W.
    Leung, Angela M.
    Livhits, Masha J.
    ENDOCRINE PATHOLOGY, 2020, 31 (04) : 377 - 384
  • [42] Ultrasound radiomics and genomics improve the diagnosis of cytologically indeterminate thyroid nodules
    Chen, Lu
    Zhang, Mingbo
    Luo, Yukun
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [43] Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers
    Marmor, Hannah N.
    Jackson, Laurel
    Gawel, Susan
    Kammer, Michael
    Massion, Pierre P.
    Grogan, Eric L.
    Davis, Gerard J.
    Deppen, Stephen A.
    CLINICA CHIMICA ACTA, 2022, 534 : 106 - 114
  • [44] OVERVIEW OF MOLECULAR BIOMARKERS FOR ENHANCING THE MANAGEMENT OF CYTOLOGICALLY INDETERMINATE THYROID NODULES AND THYROID CANCER
    Duick, Daniel S.
    ENDOCRINE PRACTICE, 2012, 18 (04) : 611 - 615
  • [45] BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
    Pongsapich, Warut
    Chongkolwatana, Cheerasook
    Poungvarin, Naravat
    Amornpichetkul, Kanchana
    Piyawattayakorn, Nutthaya
    Vejvisithsakul, Pichpisith
    Maneeprasopchoke, Prachya
    ONCOTARGETS AND THERAPY, 2019, 12 : 1465 - 1473
  • [46] UTILITY OF CORRELATION BETWEEN TI-RADS AND BETHESDA CLASSIFICATION TO ESTIMATE RISK OF MALIGNANCY FOR CYTOLOGICALLY INDETERMINATE THYROID NODULES
    Chereau, N.
    Menegaux, F.
    Bertin, J-B
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [47] Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
    Polavarapu, Preethi
    Fingeret, Abbey
    Yuil-Valdes, Ana
    Olson, Daniel
    Patel, Anery
    Shivaswamy, Vijay
    Matthias, Troy D.
    Goldner, Whitney
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (11)
  • [48] Serum TSH as a predictor of malignancy in indeterminate thyroid nodules
    Amado, A.
    Castro, B.
    Torre, A. P.
    Graca, S.
    Tavares, A.
    Povoa, A.
    Soares, C.
    Goncalves, G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (05) : 380 - 384
  • [49] Incidence and malignancy rates of indeterminate pediatric thyroid nodules
    Wang, Huiying
    Mehrad, Mitra
    Ely, Kim A.
    Liang, Jiancong
    Solorzano, Carmen C.
    Neblett, Wallace W.
    Coogan, Alice C.
    Weiss, Vivian L.
    CANCER CYTOPATHOLOGY, 2019, 127 (04) : 231 - 239
  • [50] Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management
    Linwah Yip
    Current Surgery Reports, 2 (1)